<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Endocr Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Endocr. Rev</journal-id>
<journal-id journal-id-type="hwp">edrv</journal-id>
<journal-id journal-id-type="publisher-id">endre</journal-id>
<journal-id journal-id-type="pmc">edrv</journal-id>
<journal-id journal-id-type="publisher-id">edrv</journal-id>
<journal-title-group>
<journal-title>Endocrine Reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">0163-769X</issn>
<issn pub-type="epub">1945-7189</issn>
<publisher>
<publisher-name>Endocrine Society</publisher-name>
<publisher-loc>Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27196727</article-id>
<article-id pub-id-type="pmc">4971309</article-id>
<article-id pub-id-type="publisher-id">ER-16-1007</article-id>
<article-id pub-id-type="doi">10.1210/er.2016-1007</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estrogens, Neuroinflammation, and Neurodegeneration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Villa</surname>
<given-names>Alessandro</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vegeto</surname>
<given-names>Elisabetta</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poletti</surname>
<given-names>Angelo</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Maggi</surname>
<given-names>Adriana</given-names>
</name>
</contrib>
<aff>Center of Excellence on Neurodegenerative Diseases and Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy</aff>
</contrib-group>
<author-notes>
<corresp>Address all correspondence and requests for reprints to: Adriana Maggi, PhD, <addr-line>Center of Excellence on Neurodegenerative Diseases and Department of Pharmacological and Biomolecular Sciences, University of Milan, via Balzaretti 9, I-20133 Milan, Italy.</addr-line> E-mail: <email>adriana.maggi@unimi.it</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>8</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>37</volume>
<issue>4</issue>
<fpage>372</fpage>
<lpage>402</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>1</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2016 by the Endocrine Society</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="zef00416000372.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Inflammatory activation of microglia is a hallmark of several disorders of the central nervous system. In addition to protecting the brain against inflammatory insults, microglia are neuroprotective and play a significant role in maintaining neuronal connectivity, but the prolongation of an inflammatory status may limit the beneficial functions of these immune cells. The finding that estrogen receptors are present in monocyte-derived cells and that estrogens prevent and control the inflammatory response raise the question of the role that this sex steroid plays in the manifestation and progression of pathologies that have a clear sex difference in prevalence, such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The present review aims to provide a critical review of the current literature on the actions of estrogen in microglia and on the involvement of estrogen receptors in the manifestation of selected neurological disorders. This current understanding highlights a research area that should be expanded to identify appropriate replacement therapies to slow the progression of such diseases.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>